Skip to main content

Research & Development

Research

Research Home

Our Research Strategy In Brief

Since the launch of our peer-reviewed grant program in 2002, we have supported research projects that span discovery science, physiological and psychosocial characterization our community, to innovative cellular and animal models of disease. As Barth syndrome science has matured, so too has our approach. 

Announced in 2021, our new Strategic Plan includes an expansion of Research alongside Development efforts to get to safe therapies faster for our community of Barth syndrome-affected individuals and families.  

With an R&D portfolio that spans Barth discovery and translational science, to clinical studies and trials, BSF aims to partner across sectors including academia, industry, government, and peer organizations to develop life-changing therapies and lessen the suffering caused by Barth syndrome. 

Research & Development Priorities
  • Understanding the etiology of Barth syndrome 
  • Developing impactful therapies for our community 
  • Fostering an open, inclusive, and collaborative research environment (including research tools) 

These are the lens through which BSF assesses funding opportunities and initiates R&D programs. 

How We Advance Research & Development 

Peer-reviewed Funding Opportunities 

Resource-sharing and Research Tools 

These programs span the scope of efforts BSF employs to expeditiously reach our goal of safe and effective therapies for our community. 

Learn more about BSF's R&D strategy here.

What We Do

Announcing the Iris L. Gonzalez Prize

BSF is thrilled to announce the creation of the Iris L. Gonzalez Prize (“Prize”) to advance our collective understanding of genetic variants of Barth syndrome.  Generously supported by the Paula and Woody Varner Fund, BSF will award a $10,000 prize to an individual or team proposing innovative use of BSF’s acclaimed Tafazzin Human Variants Database. Through this open competition, BSF seeks to identify ideas bearing the most potential to accelerate the mission of BSF with the Prize recipient presenting the results at BSF’s 2024 International Scientific, Medical and Family Conference.  

The Human TAFAZZIN Variants Database (“database”) is a critically useful, noncompetitive resource for the entire Barth syndrome (BTHS) community. As a valuable hypothesis-generating tool, the database has informed research efforts, diagnostic testing panels, as well as families who have sought to understand more about their diagnosis. Initiated 23 years ago and meticulously curated by Dr. Iris L. Gonzalez, the database now encompasses:  

  • >350 disease-causing or pathogenic variants  
  • >140 variants of unknown significance (due to insufficient data or as defined by American College of Medical Genetics pathogenicity guidelines)  
  • >200 non-specific polymorphisms or benign variants 

Alongside the Prize Organizing and Review Committee (ORC), our first order of business is to develop the selection criteria, with a plan to open submissions in July of this year. To keep up to date on everything related to Barth syndrome research, visit barthsyndrome.org/research

 

 

 

  • Get Involved
    Get Involved

    Volunteer
    Improve your community by joining our cause. Volunteers are integral to our organization.
    Volunteer Opportunities

MENU CLOSE